Resolution criteria
This market will resolve to "Yes" if Jose Luis Ricon provides verifiable evidence that he has undergone the "SystemAge" test offered by Generation Lab at any point on or before December 31, 2031. Verifiable evidence may include, but is not limited to, a public post (e.g., on X/Twitter, a blog, or personal website) featuring his test results, a confirmation receipt, or a public statement acknowledging completion of the test.
If no such evidence is made public or provided by the deadline, the market will resolve to "No."
Background
Generation Lab is a company co-founded by longevity researcher Dr. Irina Conboy and CEO Alina Su. The company's flagship product, the "SystemAge" test, is an epigenetic test that analyzes DNA methylation biomarkers to estimate the biological age of 19 distinct organ systems. The test is marketed as a clinical-grade diagnostic tool intended to provide actionable insights for preventive health and aging reversal. Jose Luis Ricon is a researcher and writer often involved in the longevity and tech communities.
This description was generated by AI. Review and verify everything here yourself. You can edit, replace, or delete any part of this description, including the resolution criteria. You do not need to trust the AI output.